Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

The Positive Impact of CFTR Modulators: a Year-Over-Year Comparison

December 22, 2020

Current CFTR modulator usage increased from nearly half of respondents in 2019, when three modulators were approved, to 68% in 2020.

Migraine Patient-Reported Survey Data

December 16, 2020

New Health Union survey data show patients experience a very high number of symptoms and triggers, reinforcing that migraine is "more than just a headache."

Inflammatory Bowel Disease Patient-Reported Survey Data

December 11, 2020

New survey data from Health Union reveals that half of respondents living with inflammatory bowel disease experience symptoms 15+ days per month.

HIV Patient-Reported Survey Data

December 7, 2020

New survey data shows 90% of people living with HIV feel controlled on their current treatment plan, but continue to struggle with great challenges.

Atopic Dermatitis Patient-Reported Data | 2020

June 29, 2020

Only five percent of people living with atopic dermatitis say they know all of their triggers, according to new Health Union survey data from its community.

Macular Degeneration Patient-Reported Data | 2020

June 26, 2020

Just 45% of people living with macular degeneration feel controlled on their current treatment plan, according to Health Union survey data.

White Paper: COVID-19 and Chronic Health Conditions

June 24, 2020

To develop and deliver patient-centered solutions now, it’s crucial to monitor the lifecycle of patient attitudes and behaviors in this global pandemic.

Prostate Cancer Patient-Reported Data | 2020

June 22, 2020

58% of people with prostate cancer experienced emotional or mental health changes since their diagnosis, according to Health Union survey data.

Healthcare Industry Thought Leadership

Contact